Illumina (NASDAQ:ILMN) stock dips as Scotiabank downgrades. However, peers Danaher (DHR) stock and Thermo Fisher (TMO) stock win upgrades. Read more here.

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs.

Startups are challenging market leader Illumina Inc. in the race to lower the cost of DNA sequencing and expand use of the technology throughout research and medicine. DNA sequencing lets ...

Illumina Inc , the top maker of DNA sequencers used to speed drug development and other research, on Thursday announced the launch of its next-generation NovaSeq X systems, which it said can ...

Every living cell must interpret its genetic code—a sequence of chemical letters that governs countless cellular functions. A ...

It’s been nearly 15 years since San Diego’s Illumina gained supremacy in DNA sequencing — with just a few rivals competing to deliver the equipment and chemistry to map the genome. But that ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s ...

Genomics giant Illumina launched a new line of DNA sequencers, ratcheting up the race to read genetic information accurately and cheaply.

Illumina is rolling out a new line of DNA analyzers that it says can read a person’s genetic code for a cost of about $200.

Scientists have found genetic evidence of an ancient group of people in Colombia with no modern-day descendants. It’s as if ...

Gene sequencers help determine the sequence of DNA or RNA, allowing scientists to study genetic variations associated with diseases and diagnose rare genetic conditions.